NCT02570308tebentafusptebentafusp-treateduveal melanomamUMImmTAC
…hase 2 trial of tebentafusp-treated HLA-A*02:01+ mUM patients ( NCT02570308) were used to quantify CD3+ cells by immunohistochemistry (n=11…
1articles mentioning institutions
2institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT02570308 ×
NCT02570308
This institution is selected. Its supporting articles are shown below.